Roche proposes novel pricing plan for new drugs
The manufacturer's proposed model is similar to that used in other European countries, where patients get access to new medicines while prices are being negotiated
Roche, a major global pharmaceutical manufacturer, has urged the government to pilot a new payment model that would enable patients in Ireland to get early access to innovative new drugs.
Roche’s proposed model is similar to that used in other European countries, where patients get access to new medicines while prices are being negotiated.
Roche has a new medicine called Ocrelizumab (trade name Ocrevus), which was recently approved by the European Medicines Agency. ...
